Median Strengthens its iBiopsy® Leadership Team With the Appointment of Thomas Bonnefont as Chief Operating and Commercial Officer and the Appointment of Mike Doherty as Sr. Strategy Advisor, Product Development
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210225005836/en/
Thomas Bonnefont (Photo: Median Technologies)
Median Technologies (ALMDT:PA) (Paris:ALMDT) announced today the appointment of Thomas Bonnefont to the newly created position of Chief Operating and Commercial Officer of the iBiopsy® Business Unit as well as the appointment of Mike Doherty as Sr. Strategy Advisor, iBiopsy® Product Develop...